321 related articles for article (PubMed ID: 23550771)
1. The expression of hypoxia-inducible factor-1 in primary brain tumors.
Reszec J; Rutkowski R; Chyczewski L
Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
[TBL] [Abstract][Full Text] [Related]
2. Microvessel density in brain tumors.
Assimakopoulou M; Sotiropoulou-Bonikou G; Maraziotis T; Papadakis N; Varakis I
Anticancer Res; 1997; 17(6D):4747-53. PubMed ID: 9494601
[TBL] [Abstract][Full Text] [Related]
3. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
van de Nes JA; Griewank KG; Schmid KW; Grabellus F
Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of mast cells and hypoxia inducible factor-1 expression in meningiomas of various grades in correlation with peritumoral brain edema.
Reszec J; Hermanowicz A; Rutkowski R; Bernaczyk P; Mariak Z; Chyczewski L
J Neurooncol; 2013 Oct; 115(1):119-25. PubMed ID: 23877362
[TBL] [Abstract][Full Text] [Related]
5. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
6. Expression of GLUT3 and HIF-1
Mei T; Wang Z; Wu J; Liu X; Tao W; Wang S; Chen F
Biomed Res Int; 2020; 2020():1682352. PubMed ID: 32908869
[TBL] [Abstract][Full Text] [Related]
7. Association between laminin γ1 expression and meningioma grade, recurrence, and progression-free survival.
Ke HL; Ke RH; Li B; Wang XH; Wang YN; Wang XQ
Acta Neurochir (Wien); 2013 Jan; 155(1):165-71. PubMed ID: 23053286
[TBL] [Abstract][Full Text] [Related]
8. Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens.
Cheng LL; Chang IW; Louis DN; Gonzalez RG
Cancer Res; 1998 May; 58(9):1825-32. PubMed ID: 9581820
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical study of HER2 expression in meningioma and its correlation with tumor grade.
Mahzouni P; Movahedipour M
Pathol Res Pract; 2012 Apr; 208(4):221-4. PubMed ID: 22420924
[TBL] [Abstract][Full Text] [Related]
11. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
Waage IS; Vreim I; Torp SH
Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
[TBL] [Abstract][Full Text] [Related]
13. Expression of Ki-67 and p53 in meningiomas.
Pavelin S; Becic K; Forempoher G; Mrklic I; Pogorelic Z; Titlic M; Andelinovic S
Neoplasma; 2013; 60(5):480-5. PubMed ID: 23790165
[TBL] [Abstract][Full Text] [Related]
14. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
Ozen O; Demirhan B; Altinörs N
Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
[TBL] [Abstract][Full Text] [Related]
15. Microvascularization and expression of VEGF and its receptors in recurring meningiomas: pathobiological data in favor of anti-angiogenic therapy approaches.
Preusser M; Hassler M; Birner P; Rudas M; Acker T; Plate KH; Widhalm G; Knosp E; Breitschopf H; Berger J; Marosi C
Clin Neuropathol; 2012; 31(5):352-60. PubMed ID: 22541785
[TBL] [Abstract][Full Text] [Related]
16. A glioblastoma arising from the attached region where a meningioma had been totally removed.
Ohba S; Shimizu K; Shibao S; Miwa T; Nakagawa T; Sasaki H; Murakami H
Neuropathology; 2011 Dec; 31(6):606-11. PubMed ID: 21284750
[TBL] [Abstract][Full Text] [Related]
17. SP100 reduces malignancy of human glioma cells.
Held-Feindt J; Hattermann K; Knerlich-Lukoschus F; Mehdorn HM; Mentlein R
Int J Oncol; 2011 Apr; 38(4):1023-30. PubMed ID: 21274506
[TBL] [Abstract][Full Text] [Related]
18. DNA content is associated with malignancy of intracranial neoplasms.
Alexiou GA; Vartholomatos E; Goussia A; Dova L; Karamoutsios A; Fotakopoulos G; Kyritsis AP; Voulgaris S
Clin Neurol Neurosurg; 2013 Sep; 115(9):1784-7. PubMed ID: 23683441
[TBL] [Abstract][Full Text] [Related]
19. Meningiomas and gliomas in juxtaposition: casual or causal coexistence? Report of two cases.
Matyja E; Kuchna I; Kroh H; Mazurowski W; Zabek M
Am J Surg Pathol; 1995 Jan; 19(1):37-41. PubMed ID: 7802136
[TBL] [Abstract][Full Text] [Related]
20. A hypoxia-inducible factor (HIF)-3α splicing variant, HIF-3α4 impairs angiogenesis in hypervascular malignant meningiomas with epigenetically silenced HIF-3α4.
Ando H; Natsume A; Iwami K; Ohka F; Kuchimaru T; Kizaka-Kondoh S; Ito K; Saito K; Sugita S; Hoshino T; Wakabayashi T
Biochem Biophys Res Commun; 2013 Mar; 433(1):139-44. PubMed ID: 23485455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]